"But a fundamental question still remained at the end of that study: Does HDAC3 regulate any gene program that is shared ...
本文研究结果表明，在恩替诺特和曲美替尼组合性疗法存在的前提下，T细胞或能促进对体内肿瘤生长的控制，同时HDAC3或能作为T细胞招募到KRAS突变 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback